Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pharmacogenomics-Supported Psychotropic Prescribing Trial
Sponsor: University of Manitoba
Summary
Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in Manitoba.
Official title: Pharmacogenomics-Supported Psychotropic Prescribing Trial (PGx-SUPPORT): A Pilot Implementation Study in Manitoba
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2025-07-01
Completion Date
2030-12-31
Last Updated
2025-09-08
Healthy Volunteers
No
Interventions
Pharmacogenetic Testing
Participants will donate a 1ml (one-fifth of a teaspoon) sample of saliva. DNA extracted from the saliva sample will be used for genotyping. Genotyping results will be translated into an interpretative clinical report using evidence-based software (Sequence2Script) and delivered to the treating physician for use in their clinical decision-making. The report will contain genotyping results, predicted phenotype, and evidence-based drug selection and dosing recommendations relevant to the patient's current and future care.
Locations (2)
Shared Health Facilities
Winnipeg, Manitoba, Canada
University of Manitoba College of Pharmacy
Winnipeg, Manitoba, Canada